Skip to main content

Jordi Rello Condomines

Clinical and epidemiologic research in pneumonia & Sepsis CIBERES Network- Node 18

Institutions of which they are part

Head of group
Clinical Research/Innovation in Pneumonia & Sepsis (CRIPS)
Vall Hebron Institut de Recerca

Jordi Rello Condomines

Institutions of which they are part

Head of group
Clinical Research/Innovation in Pneumonia & Sepsis (CRIPS)
Vall Hebron Institut de Recerca

Clinical and epidemiologic research in pneumonia & Sepsis CIBERES Network- Node 18

ORCID: 0000 0003 0676 6210

H-Index 118.
google Scholar (accessed sept 14th, 2021)
50495 citations (4353 in 2020)

Web of Science P-2402-2019

Research lines

Severe Acute Respiratory Infections (SARI)

To focus on the most prevalent aspects of SARI: Pneumococcal CAP, Viral VAP, Pseudomonas VAP, & MRSA VAP

IP: Rello Condomines, Jordi

Projects

Clinical Research and Epidemiology in Pneumonia & Sepsis (CRIPS)

IP: Rello Condomines, Jordi
Collaborators: -
Funding agency: AGAUR no fer servir-correcte 4301-37
Funding: 0.01
Reference: 2017SGR01671
Duration: 01/01/2017 - 31/12/2020

Sol·licitud per estada a la University of Liverpool per al projecte "Pharmacokinetic Modelling for the individualisation of Antimicrobial Therapy in the Critically Ill"

IP: Rello Condomines, Jordi
Collaborators: Perez Lasarte, Laia
Funding agency: Instituto de Salud Carlos III
Funding: 6000
Reference: M_AES16/00012
Duration: 01/10/2016 - 31/12/2016

Clinical Research / Innovation in Pneumonia & Sepsis (CRIPS) (GRC)

IP: Rello Condomines, Jordi
Collaborators: Diaz Lagares, Candido, Peña Lopez, Yolanda, Riera del Brío, Jordi, Pont Castellana, Teresa
Funding agency: AGAUR no fer servir-correcte 4301-37
Funding: 28800
Reference: 2014 SGR 278
Duration: 01/01/2014 - 31/12/2016

Evaluación Prospectiva de la Pro-Calictonina y Pro-Adrenomedullina como Biomarcadores de Infección en Pacientes con Traqueobronquitis Asociada a la Ventilación Mecánica (BioVAT).

IP: Rello Condomines, Jordi
Collaborators: Perez Lasarte, Laia
Funding agency: Instituto de Salud Carlos III
Funding: 53732
Reference: CM14/00212
Duration: 01/01/2015 - 31/12/2016

Related news

A study, in which Vall d'Hebron has participated, has analysed all the interventions of this type carried out between 2006 and 2020.

The work of the multinational team, which has reviewed the records of more than one million patients who have received a new organ, has found significant differences between women and men

The scientific review reports that changes in the respiratory system flora due to pollution increase the risk of suffering a hospital infection caused by multidrug-resistant organisms.

Related professionals

Imane Boutitah Benyaich

Imane Boutitah Benyaich

Predoctoral researcher
Clinical Neuroimmunology
Read more
Milagros Mejia

Milagros Mejia

Administration and Management
Cardiovascular Diseases
Read more
Sonia Carramiñana Mayor

Sonia Carramiñana Mayor

Research technician
Liver Diseases
Read more
Lorenzo Escutia Mari

Lorenzo Escutia Mari

Research technician
Research on Aging, Frailty and Transitions in Barcelona
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.